Cargando…
The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-tre...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075844/ https://www.ncbi.nlm.nih.gov/pubmed/31399801 http://dx.doi.org/10.1007/s00259-019-04460-y |
Sumario: | PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-treatment analysis of distribution. The aim of this study was to analyze the agreement between (166)Ho-scout and (166)Ho-therapeutic dose in comparison with the agreement between (99m)Tc-MAA and (166)Ho-therapeutic dose. METHODS: Two separate scout dose procedures were performed ((99m)Tc-MAA and (166)Ho-scout) before treatment in 53 patients. First, qualitative assessment was performed by two blinded nuclear medicine physicians who visually rated the agreement between the (99m)Tc-MAA, (166)Ho-scout, and (166)Ho-therapeutic dose SPECT-scans (i.e., all performed in the same patient) on a 5-point scale. Second, agreement was measured quantitatively by delineating lesions and normal liver on FDG-PET/CT. These volumes of interest (VOIs) were co-registered to the SPECT/CT images. The predicted absorbed doses (based on (99m)Tc-MAA and (166)Ho-scout) were compared with the actual absorbed dose on post-treatment SPECT. RESULTS: A total of 23 procedures (71 lesions, 22 patients) were included for analysis. In the qualitative analysis, (166)Ho-scout was superior with a median score of 4 vs. 2.5 for (99m)Tc-MAA (p < 0.001). The quantitative analysis showed significantly narrower 95%-limits of agreement for (166)Ho-scout in comparison with (99m)Tc-MAA when evaluating lesion absorbed dose (− 90.3 and 105.3 Gy vs. − 164.1 and 197.0 Gy, respectively). Evaluation of normal liver absorbed dose did not show difference in agreement between both scout doses and (166)Ho-therapeutic dose (− 2.9 and 5.5 Gy vs − 3.6 and 4.1 Gy for (99m)Tc-MAA and (166)Ho-scout, respectively). CONCLUSIONS: In this study, (166)Ho-scout was shown to have a superior predictive value for intrahepatic distribution in comparison with (99m)Tc-MAA. |
---|